The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-inflammatory Serums Market Research Report 2025
Synopsis
Anti-inflammatory Serums
The global Anti-inflammatory Serums market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-inflammatory Serums is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-inflammatory Serums is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-inflammatory Serums include The Ordinary, La Roche-Posay, SkinCeutical, Medik8, Dermalogica, Proya, Cosmedix, ULUKA and SAFERO, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Serums, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Serums.
Report Scope
The Anti-inflammatory Serums market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Serums market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Serums manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Ordinary
La Roche-Posay
SkinCeutical
Medik8
Dermalogica
Proya
Cosmedix
ULUKA
SAFERO
John Jeff
Biophyto-genesis
PURID
UNISKIN
Brandfree
Segment by Type
CBD
Blue Copper Peptide
Resveratrol
Others
Segment by Application
Online Retail
Offline Retail
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-inflammatory Serums manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-inflammatory Serums in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Anti-inflammatory Serums
The global Anti-inflammatory Serums market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Anti-inflammatory Serums is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anti-inflammatory Serums is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Anti-inflammatory Serums include The Ordinary, La Roche-Posay, SkinCeutical, Medik8, Dermalogica, Proya, Cosmedix, ULUKA and SAFERO, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Serums, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Serums.
Report Scope
The Anti-inflammatory Serums market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Serums market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-inflammatory Serums manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
The Ordinary
La Roche-Posay
SkinCeutical
Medik8
Dermalogica
Proya
Cosmedix
ULUKA
SAFERO
John Jeff
Biophyto-genesis
PURID
UNISKIN
Brandfree
Segment by Type
CBD
Blue Copper Peptide
Resveratrol
Others
Segment by Application
Online Retail
Offline Retail
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-inflammatory Serums manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-inflammatory Serums in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-inflammatory Serums Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Serums
1.2 Anti-inflammatory Serums Segment by Type
1.2.1 Global Anti-inflammatory Serums Market Value Comparison by Type (2024-2030)
1.2.2 CBD
1.2.3 Blue Copper Peptide
1.2.4 Resveratrol
1.2.5 Others
1.3 Anti-inflammatory Serums Segment by Application
1.3.1 Global Anti-inflammatory Serums Market Value by Application: (2024-2030)
1.3.2 Online Retail
1.3.3 Offline Retail
1.4 Global Anti-inflammatory Serums Market Size Estimates and Forecasts
1.4.1 Global Anti-inflammatory Serums Revenue 2019-2030
1.4.2 Global Anti-inflammatory Serums Sales 2019-2030
1.4.3 Global Anti-inflammatory Serums Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-inflammatory Serums Market Competition by Manufacturers
2.1 Global Anti-inflammatory Serums Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-inflammatory Serums Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-inflammatory Serums Average Price by Manufacturers (2019-2024)
2.4 Global Anti-inflammatory Serums Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-inflammatory Serums, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-inflammatory Serums, Product Type & Application
2.7 Anti-inflammatory Serums Market Competitive Situation and Trends
2.7.1 Anti-inflammatory Serums Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-inflammatory Serums Players Market Share by Revenue
2.7.3 Global Anti-inflammatory Serums Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-inflammatory Serums Retrospective Market Scenario by Region
3.1 Global Anti-inflammatory Serums Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-inflammatory Serums Global Anti-inflammatory Serums Sales by Region: 2019-2030
3.2.1 Global Anti-inflammatory Serums Sales by Region: 2019-2024
3.2.2 Global Anti-inflammatory Serums Sales by Region: 2025-2030
3.3 Global Anti-inflammatory Serums Global Anti-inflammatory Serums Revenue by Region: 2019-2030
3.3.1 Global Anti-inflammatory Serums Revenue by Region: 2019-2024
3.3.2 Global Anti-inflammatory Serums Revenue by Region: 2025-2030
3.4 North America Anti-inflammatory Serums Market Facts & Figures by Country
3.4.1 North America Anti-inflammatory Serums Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-inflammatory Serums Sales by Country (2019-2030)
3.4.3 North America Anti-inflammatory Serums Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Anti-inflammatory Serums Market Facts & Figures by Country
3.5.1 Europe Anti-inflammatory Serums Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-inflammatory Serums Sales by Country (2019-2030)
3.5.3 Europe Anti-inflammatory Serums Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-inflammatory Serums Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-inflammatory Serums Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-inflammatory Serums Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-inflammatory Serums Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Anti-inflammatory Serums Market Facts & Figures by Country
3.7.1 Latin America Anti-inflammatory Serums Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-inflammatory Serums Sales by Country (2019-2030)
3.7.3 Latin America Anti-inflammatory Serums Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-inflammatory Serums Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-inflammatory Serums Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-inflammatory Serums Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-inflammatory Serums Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Anti-inflammatory Serums Sales by Type (2019-2030)
4.1.1 Global Anti-inflammatory Serums Sales by Type (2019-2024)
4.1.2 Global Anti-inflammatory Serums Sales by Type (2025-2030)
4.1.3 Global Anti-inflammatory Serums Sales Market Share by Type (2019-2030)
4.2 Global Anti-inflammatory Serums Revenue by Type (2019-2030)
4.2.1 Global Anti-inflammatory Serums Revenue by Type (2019-2024)
4.2.2 Global Anti-inflammatory Serums Revenue by Type (2025-2030)
4.2.3 Global Anti-inflammatory Serums Revenue Market Share by Type (2019-2030)
4.3 Global Anti-inflammatory Serums Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-inflammatory Serums Sales by Application (2019-2030)
5.1.1 Global Anti-inflammatory Serums Sales by Application (2019-2024)
5.1.2 Global Anti-inflammatory Serums Sales by Application (2025-2030)
5.1.3 Global Anti-inflammatory Serums Sales Market Share by Application (2019-2030)
5.2 Global Anti-inflammatory Serums Revenue by Application (2019-2030)
5.2.1 Global Anti-inflammatory Serums Revenue by Application (2019-2024)
5.2.2 Global Anti-inflammatory Serums Revenue by Application (2025-2030)
5.2.3 Global Anti-inflammatory Serums Revenue Market Share by Application (2019-2030)
5.3 Global Anti-inflammatory Serums Price by Application (2019-2030)
6 Key Companies Profiled
6.1 The Ordinary
6.1.1 The Ordinary Corporation Information
6.1.2 The Ordinary Description and Business Overview
6.1.3 The Ordinary Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.1.4 The Ordinary Anti-inflammatory Serums Product Portfolio
6.1.5 The Ordinary Recent Developments/Updates
6.2 La Roche-Posay
6.2.1 La Roche-Posay Corporation Information
6.2.2 La Roche-Posay Description and Business Overview
6.2.3 La Roche-Posay Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.2.4 La Roche-Posay Anti-inflammatory Serums Product Portfolio
6.2.5 La Roche-Posay Recent Developments/Updates
6.3 SkinCeutical
6.3.1 SkinCeutical Corporation Information
6.3.2 SkinCeutical Description and Business Overview
6.3.3 SkinCeutical Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SkinCeutical Anti-inflammatory Serums Product Portfolio
6.3.5 SkinCeutical Recent Developments/Updates
6.4 Medik8
6.4.1 Medik8 Corporation Information
6.4.2 Medik8 Description and Business Overview
6.4.3 Medik8 Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medik8 Anti-inflammatory Serums Product Portfolio
6.4.5 Medik8 Recent Developments/Updates
6.5 Dermalogica
6.5.1 Dermalogica Corporation Information
6.5.2 Dermalogica Description and Business Overview
6.5.3 Dermalogica Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Dermalogica Anti-inflammatory Serums Product Portfolio
6.5.5 Dermalogica Recent Developments/Updates
6.6 Proya
6.6.1 Proya Corporation Information
6.6.2 Proya Description and Business Overview
6.6.3 Proya Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Proya Anti-inflammatory Serums Product Portfolio
6.6.5 Proya Recent Developments/Updates
6.7 Cosmedix
6.6.1 Cosmedix Corporation Information
6.6.2 Cosmedix Description and Business Overview
6.6.3 Cosmedix Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cosmedix Anti-inflammatory Serums Product Portfolio
6.7.5 Cosmedix Recent Developments/Updates
6.8 ULUKA
6.8.1 ULUKA Corporation Information
6.8.2 ULUKA Description and Business Overview
6.8.3 ULUKA Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.8.4 ULUKA Anti-inflammatory Serums Product Portfolio
6.8.5 ULUKA Recent Developments/Updates
6.9 SAFERO
6.9.1 SAFERO Corporation Information
6.9.2 SAFERO Description and Business Overview
6.9.3 SAFERO Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.9.4 SAFERO Anti-inflammatory Serums Product Portfolio
6.9.5 SAFERO Recent Developments/Updates
6.10 John Jeff
6.10.1 John Jeff Corporation Information
6.10.2 John Jeff Description and Business Overview
6.10.3 John Jeff Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.10.4 John Jeff Anti-inflammatory Serums Product Portfolio
6.10.5 John Jeff Recent Developments/Updates
6.11 Biophyto-genesis
6.11.1 Biophyto-genesis Corporation Information
6.11.2 Biophyto-genesis Anti-inflammatory Serums Description and Business Overview
6.11.3 Biophyto-genesis Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Biophyto-genesis Anti-inflammatory Serums Product Portfolio
6.11.5 Biophyto-genesis Recent Developments/Updates
6.12 PURID
6.12.1 PURID Corporation Information
6.12.2 PURID Anti-inflammatory Serums Description and Business Overview
6.12.3 PURID Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.12.4 PURID Anti-inflammatory Serums Product Portfolio
6.12.5 PURID Recent Developments/Updates
6.13 UNISKIN
6.13.1 UNISKIN Corporation Information
6.13.2 UNISKIN Anti-inflammatory Serums Description and Business Overview
6.13.3 UNISKIN Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.13.4 UNISKIN Anti-inflammatory Serums Product Portfolio
6.13.5 UNISKIN Recent Developments/Updates
6.14 Brandfree
6.14.1 Brandfree Corporation Information
6.14.2 Brandfree Anti-inflammatory Serums Description and Business Overview
6.14.3 Brandfree Anti-inflammatory Serums Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Brandfree Anti-inflammatory Serums Product Portfolio
6.14.5 Brandfree Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-inflammatory Serums Industry Chain Analysis
7.2 Anti-inflammatory Serums Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-inflammatory Serums Production Mode & Process
7.4 Anti-inflammatory Serums Sales and Marketing
7.4.1 Anti-inflammatory Serums Sales Channels
7.4.2 Anti-inflammatory Serums Distributors
7.5 Anti-inflammatory Serums Customers
8 Anti-inflammatory Serums Market Dynamics
8.1 Anti-inflammatory Serums Industry Trends
8.2 Anti-inflammatory Serums Market Drivers
8.3 Anti-inflammatory Serums Market Challenges
8.4 Anti-inflammatory Serums Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Anti-inflammatory Serums Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Anti-inflammatory Serums Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Anti-inflammatory Serums Market Competitive Situation by Manufacturers in 2023
Table 4. Global Anti-inflammatory Serums Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Anti-inflammatory Serums Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Anti-inflammatory Serums Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Anti-inflammatory Serums Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Anti-inflammatory Serums Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Anti-inflammatory Serums, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Anti-inflammatory Serums, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Anti-inflammatory Serums, Product Type & Application
Table 12. Global Key Manufacturers of Anti-inflammatory Serums, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Anti-inflammatory Serums by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Serums as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti-inflammatory Serums Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Anti-inflammatory Serums Sales by Region (2019-2024) & (K Units)
Table 18. Global Anti-inflammatory Serums Sales Market Share by Region (2019-2024)
Table 19. Global Anti-inflammatory Serums Sales by Region (2025-2030) & (K Units)
Table 20. Global Anti-inflammatory Serums Sales Market Share by Region (2025-2030)
Table 21. Global Anti-inflammatory Serums Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Anti-inflammatory Serums Revenue Market Share by Region (2019-2024)
Table 23. Global Anti-inflammatory Serums Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Anti-inflammatory Serums Revenue Market Share by Region (2025-2030)
Table 25. North America Anti-inflammatory Serums Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 27. North America Anti-inflammatory Serums Sales by Country (2025-2030) & (K Units)
Table 28. North America Anti-inflammatory Serums Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Anti-inflammatory Serums Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Anti-inflammatory Serums Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 32. Europe Anti-inflammatory Serums Sales by Country (2025-2030) & (K Units)
Table 33. Europe Anti-inflammatory Serums Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Anti-inflammatory Serums Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Anti-inflammatory Serums Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Anti-inflammatory Serums Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Anti-inflammatory Serums Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Anti-inflammatory Serums Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Anti-inflammatory Serums Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Anti-inflammatory Serums Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Anti-inflammatory Serums Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Anti-inflammatory Serums Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Anti-inflammatory Serums Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Anti-inflammatory Serums Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Anti-inflammatory Serums Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Anti-inflammatory Serums Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Anti-inflammatory Serums Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Anti-inflammatory Serums Sales (K Units) by Type (2019-2024)
Table 51. Global Anti-inflammatory Serums Sales (K Units) by Type (2025-2030)
Table 52. Global Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
Table 53. Global Anti-inflammatory Serums Sales Market Share by Type (2025-2030)
Table 54. Global Anti-inflammatory Serums Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Anti-inflammatory Serums Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Anti-inflammatory Serums Revenue Market Share by Type (2019-2024)
Table 57. Global Anti-inflammatory Serums Revenue Market Share by Type (2025-2030)
Table 58. Global Anti-inflammatory Serums Price (USD/Unit) by Type (2019-2024)
Table 59. Global Anti-inflammatory Serums Price (USD/Unit) by Type (2025-2030)
Table 60. Global Anti-inflammatory Serums Sales (K Units) by Application (2019-2024)
Table 61. Global Anti-inflammatory Serums Sales (K Units) by Application (2025-2030)
Table 62. Global Anti-inflammatory Serums Sales Market Share by Application (2019-2024)
Table 63. Global Anti-inflammatory Serums Sales Market Share by Application (2025-2030)
Table 64. Global Anti-inflammatory Serums Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Anti-inflammatory Serums Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Anti-inflammatory Serums Revenue Market Share by Application (2019-2024)
Table 67. Global Anti-inflammatory Serums Revenue Market Share by Application (2025-2030)
Table 68. Global Anti-inflammatory Serums Price (USD/Unit) by Application (2019-2024)
Table 69. Global Anti-inflammatory Serums Price (USD/Unit) by Application (2025-2030)
Table 70. The Ordinary Corporation Information
Table 71. The Ordinary Description and Business Overview
Table 72. The Ordinary Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. The Ordinary Anti-inflammatory Serums Product
Table 74. The Ordinary Recent Developments/Updates
Table 75. La Roche-Posay Corporation Information
Table 76. La Roche-Posay Description and Business Overview
Table 77. La Roche-Posay Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. La Roche-Posay Anti-inflammatory Serums Product
Table 79. La Roche-Posay Recent Developments/Updates
Table 80. SkinCeutical Corporation Information
Table 81. SkinCeutical Description and Business Overview
Table 82. SkinCeutical Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. SkinCeutical Anti-inflammatory Serums Product
Table 84. SkinCeutical Recent Developments/Updates
Table 85. Medik8 Corporation Information
Table 86. Medik8 Description and Business Overview
Table 87. Medik8 Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Medik8 Anti-inflammatory Serums Product
Table 89. Medik8 Recent Developments/Updates
Table 90. Dermalogica Corporation Information
Table 91. Dermalogica Description and Business Overview
Table 92. Dermalogica Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Dermalogica Anti-inflammatory Serums Product
Table 94. Dermalogica Recent Developments/Updates
Table 95. Proya Corporation Information
Table 96. Proya Description and Business Overview
Table 97. Proya Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Proya Anti-inflammatory Serums Product
Table 99. Proya Recent Developments/Updates
Table 100. Cosmedix Corporation Information
Table 101. Cosmedix Description and Business Overview
Table 102. Cosmedix Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Cosmedix Anti-inflammatory Serums Product
Table 104. Cosmedix Recent Developments/Updates
Table 105. ULUKA Corporation Information
Table 106. ULUKA Description and Business Overview
Table 107. ULUKA Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. ULUKA Anti-inflammatory Serums Product
Table 109. ULUKA Recent Developments/Updates
Table 110. SAFERO Corporation Information
Table 111. SAFERO Description and Business Overview
Table 112. SAFERO Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. SAFERO Anti-inflammatory Serums Product
Table 114. SAFERO Recent Developments/Updates
Table 115. John Jeff Corporation Information
Table 116. John Jeff Description and Business Overview
Table 117. John Jeff Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. John Jeff Anti-inflammatory Serums Product
Table 119. John Jeff Recent Developments/Updates
Table 120. Biophyto-genesis Corporation Information
Table 121. Biophyto-genesis Description and Business Overview
Table 122. Biophyto-genesis Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Biophyto-genesis Anti-inflammatory Serums Product
Table 124. Biophyto-genesis Recent Developments/Updates
Table 125. PURID Corporation Information
Table 126. PURID Description and Business Overview
Table 127. PURID Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. PURID Anti-inflammatory Serums Product
Table 129. PURID Recent Developments/Updates
Table 130. UNISKIN Corporation Information
Table 131. UNISKIN Description and Business Overview
Table 132. UNISKIN Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. UNISKIN Anti-inflammatory Serums Product
Table 134. UNISKIN Recent Developments/Updates
Table 135. Brandfree Corporation Information
Table 136. Brandfree Description and Business Overview
Table 137. Brandfree Anti-inflammatory Serums Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Brandfree Anti-inflammatory Serums Product
Table 139. Brandfree Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Anti-inflammatory Serums Distributors List
Table 143. Anti-inflammatory Serums Customers List
Table 144. Anti-inflammatory Serums Market Trends
Table 145. Anti-inflammatory Serums Market Drivers
Table 146. Anti-inflammatory Serums Market Challenges
Table 147. Anti-inflammatory Serums Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-inflammatory Serums
Figure 2. Global Anti-inflammatory Serums Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Anti-inflammatory Serums Market Share by Type in 2023 & 2030
Figure 4. CBD Product Picture
Figure 5. Blue Copper Peptide Product Picture
Figure 6. Resveratrol Product Picture
Figure 7. Others Product Picture
Figure 8. Global Anti-inflammatory Serums Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Anti-inflammatory Serums Market Share by Application in 2023 & 2030
Figure 10. Online Retail
Figure 11. Offline Retail
Figure 12. Global Anti-inflammatory Serums Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Anti-inflammatory Serums Market Size (2019-2030) & (US$ Million)
Figure 14. Global Anti-inflammatory Serums Sales (2019-2030) & (K Units)
Figure 15. Global Anti-inflammatory Serums Average Price (USD/Unit) & (2019-2030)
Figure 16. Anti-inflammatory Serums Report Years Considered
Figure 17. Anti-inflammatory Serums Sales Share by Manufacturers in 2023
Figure 18. Global Anti-inflammatory Serums Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Anti-inflammatory Serums Players: Market Share by Revenue in 2023
Figure 20. Anti-inflammatory Serums Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Anti-inflammatory Serums Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Anti-inflammatory Serums Sales Market Share by Country (2019-2030)
Figure 23. North America Anti-inflammatory Serums Revenue Market Share by Country (2019-2030)
Figure 24. United States Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Anti-inflammatory Serums Sales Market Share by Country (2019-2030)
Figure 27. Europe Anti-inflammatory Serums Revenue Market Share by Country (2019-2030)
Figure 28. Germany Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Anti-inflammatory Serums Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Anti-inflammatory Serums Revenue Market Share by Region (2019-2030)
Figure 35. China Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Anti-inflammatory Serums Sales Market Share by Country (2019-2030)
Figure 45. Latin America Anti-inflammatory Serums Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Anti-inflammatory Serums Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Anti-inflammatory Serums Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Anti-inflammatory Serums Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Anti-inflammatory Serums by Type (2019-2030)
Figure 55. Global Revenue Market Share of Anti-inflammatory Serums by Type (2019-2030)
Figure 56. Global Anti-inflammatory Serums Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Anti-inflammatory Serums by Application (2019-2030)
Figure 58. Global Revenue Market Share of Anti-inflammatory Serums by Application (2019-2030)
Figure 59. Global Anti-inflammatory Serums Price (USD/Unit) by Application (2019-2030)
Figure 60. Anti-inflammatory Serums Value Chain
Figure 61. Anti-inflammatory Serums Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Retail Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
